ADPKD	autosomal dominant polycystic kidney disease;
Ah	arteriolar hyalinosis;
AKI	acute kidney injury;
AKIN	Acute Kidney Injury Network;
ASCVD	atherosclerotic cardiovascular disease;
AUC	area under the curve;
AUROC	area under the receiver operating characteristic curve;
BMI	body mass index;
CIT	cold ischemic time;
Ci/Ct	interstitial fibrosis/tubular atrophy;
CV	arterial intimal thickening;
CVA	cerebral vascular accident;
DDKT	deceased-donor kidney transplantation;
DGF	delayed graft function;
DM	diabetes mellitus;
ECD	expanded criteria donor;
ESKD	end-stage kidney disease;
HD	hemodialysis;
HLA	human leukocyte antigen;
HR	hazard ratio;
Ig	immunoglobulin;
IQR	interquartile range;
KT	kidney transplantation;
KTRs	kidney transplant recipients;
LRKT	living related kidney transplantation;
MICE	Multiple Imputation by Chained Equations;
ML	machine learning;
NPV	negative predictive value;
PPV	positive predictive value;
PRA	panel reactive antibody;
RRF	residual renal function;
SD	standard deviation;
UPCR	urine protein–creatinine ratio;
WIT	warm ischemic time;
XGBoost	extreme gradient boosting.